Get started
Author

Inês Maria Vaz Duarte Luis

Randomized phase II study of eribulin mesylate (E) with or without pembrolizumab (P) for hormone receptor-positive (HR+) metastatic breast cancer (MBC).
2019 · Sara M. Tolaney, Romualdo Barroso-Sousa, et al. · Journal of Clinical Oncology · 24
Cognitive impairment in breast cancer patients before surgery?: Results of a subgroup of the French CANTO cohort.
2019 · Marie Lange, Isabelle Léger, et al. · Journal of Clinical Oncology · 5
Symptom burden and employment status in breast cancer (BC) survivors.
2018 · Ines Maria Vaz Duarte Luis, Anne M. O'Neill, et al. · Journal of Clinical Oncology · 5
Impact of hormone receptor (HR) status on clinicopathological features, patterns of recurrence, and clinical outcomes among patients (pts) with human epidermal growth factor receptor-2 positive (HER2) breast cancer (BC) in the National Comprehensive Cancer Network (NCCN).
2012 · Ines Maria Vaz Duarte Luis, Rebecca A Ottesen, et al. · Journal of Clinical Oncology · 5
Differential impact of endocrine therapy (ET) and chemotherapy (CT) on quality of life (QoL) of 4,262 breast cancer (BC) survivors: A prospective patient-reported outcomes (PRO) analysis.
2019 · Arlindo R. Ferreira, Antonio Di Meglio, et al. · Journal of Clinical Oncology · 4
Time trends in the use of adjuvant chemotherapy (CTX) and outcomes in women with T1N0 breast cancer (BC) in the National Comprehensive Cancer Network (NCCN).
2013 · Ines Maria Vaz Duarte Luis, Rebecca A Ottesen, et al. · Journal of Clinical Oncology · 4
Towards improvement of oncology care through digital technology: A snapshot of Resilience remote patient monitoring (RPM) system implementation across 19 hospitals in Europe.
2023 · Arlindo R. Ferreira, Antoine Lemaire, et al. · Journal of Clinical Oncology · 3
PROACT: Implementing a PROACTive care pathway to empower and support breast cancer (BC) survivors.
2022 · Maria Alice B Franzoi, Lena Degousee, et al. · Journal of Clinical Oncology · 3
Return to work after breast cancer: Comprehensive longitudinal analyses of its determinants.
2019 · Agnes Dumas, Ines Maria Vaz Duarte Luis, et al. · Journal of Clinical Oncology · 3
Completion of adjuvant trastuzumab for older patients with early-stage breast cancer (BC).
2013 · Rachel A. Freedman, Ines Maria Vaz Duarte Luis, et al. · Journal of Clinical Oncology · 3
Factors associated with early mortality in metastatic breast cancer (MBC) in a population based cohort.
2015 · Ines Maria Vaz Duarte Luis, Nancy U. Lin, et al. · Journal of Clinical Oncology · 2
Return to work among self-employed breast cancer survivors from the CANTO cohort
2026 · Chloé Lopez, Idlir Licaj, et al. · Scientific Reports · 1
PDF
Trajectories of cancer-related behavioral symptoms (CRBS) burden after breast cancer (BC).
2024 · Martina Pagliuca, Julie Havas, et al. · Journal of Clinical Oncology · 1
PDF
Aromatase inhibitor musculoskeletal toxicity (AIMT) in patients (pts) with early breast cancer (EBC): Prevalence, management, and association with non-adherence to AI.
2024 · Pietro Lapidari, Maryam B. Lustberg, et al. · Journal of Clinical Oncology · 1
The adherence and response of a combined approach of online self-help cognitive behavioral therapy and phone-based psychological guidance among French patients with cancer with insomnia.
2024 · Diane Boinon, Arnaud Pages, et al. · Journal of Clinical Oncology · 1
PDF
Training and validation of a model predicting clusters of long-term cancer-related behavioral symptoms (CRBS) after breast cancer (BC).
2023 · Martina Pagliuca, Julie Havas, et al. · Journal of Clinical Oncology · 1
Readability and understandability of instruments for collecting patient-generated data (PGD).
2023 · Camila Kelly Chiodi, Johanna Arvis, et al. · Journal of Clinical Oncology · 1
PDF
Abstract P4-11-24: Patient's point of view on how to promote adherence to adjuvant endocrine therapy (ET): A large french survey
2022 · Sarra Akla, Elie Rassy, et al. · Cancer Research · 1
Assessing the risk of severe post-treatment (tx) cancer-related fatigue (CRF) among breast cancer survivors (BCS) in the CANcer TOxicity (CANTO) cohort.
2021 · Antonio Di Meglio, Julie Havas, et al. · Journal of Clinical Oncology · 1
Impact of overweight, obesity, and post-treatment weight changes on occupational reintegration of breast cancer (BC) survivors.
2019 · Antonio Di Meglio, Gwenn Menvielle, et al. · Journal of Clinical Oncology · 1
A phase II study of eribulin mesylate in combination with trastuzumab and pertuzumab in patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC).
2017 · Ines Maria Vaz Duarte Luis, Hao Guo, et al. · Journal of Clinical Oncology · 1
Fatigue and health behaviors in cancer survivors: A cross-sectional population based study.
2017 · Margarida Matias, Giulia Baciarello, et al. · Journal of Clinical Oncology · 1
Abstract P1-12-08: Factors associated with delays in chemotherapy initiation among patients with breast cancer
2016 · K Losk, I Vaz Duarte Luis, et al. · Cancer Research · 1
Variation in the use of granulocyte-colony stimulating factor (G-CSF) for dose dense paclitaxel: A single institution retrospective study.
2015 · Flavia Rocha Paes, Ines Maria Vaz Duarte Luis, et al. · Journal of Clinical Oncology · 1
A phase II study of eribulin mesylate in combination with trastuzumab and pertuzumab in patients (pts) with metastatic, human epidermal growth factor receptor 2-positive breast cancer.
2014 · Rachel A. Freedman, Ines Maria Vaz Duarte Luis, et al. · Journal of Clinical Oncology · 1
Works count: 40
Citation count: 77
H-index: 4
I10-index: 1
Year
Topic
Type